1. Home
  2. NEON vs INAB Comparison

NEON vs INAB Comparison

Compare NEON & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

HOLD

Current Price

$1.38

Market Cap

27.9M

Sector

Technology

ML Signal

HOLD

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$1.96

Market Cap

22.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEON
INAB
Founded
1997
2016
Country
Sweden
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
22.9M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
NEON
INAB
Price
$1.38
$1.96
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$6.00
AVG Volume (30 Days)
107.0K
35.9K
Earning Date
03-18-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
37.88
N/A
EPS
N/A
N/A
Revenue
$3,108,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$43.34
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.37
$0.12
52 Week High
$29.90
$4.20

Technical Indicators

Market Signals
Indicator
NEON
INAB
Relative Strength Index (RSI) 28.80 50.07
Support Level N/A $1.52
Resistance Level $2.01 $2.15
Average True Range (ATR) 0.09 0.17
MACD -0.02 0.01
Stochastic Oscillator 6.24 47.06

Price Performance

Historical Comparison
NEON
INAB

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

Share on Social Networks: